Today starts our final consortium meeting, a two days hybrid meeting concluding 5 incredible years with amazing results. To learn more you can still register to our Final Symposium, next Friday free & everyone is welcome.
The TUD researchers contributed to overcome translational gap by developing novel in-vivo model for the labeling of insulin secretory granule pools.
In the end of the project, the RHAPSODY team is eager to share its achievements with patient and healthcare communities and welcomes all to a public half-day symposium on September 17, 2021.
Registration is now open.
Just published in Diabetologia, a new joined study by the RHAPSODY consortium on T2D subtypes clusters: "Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study"